AzTrials
AzTrials

DepressionPhase 2NCT00074789

Reducing Symptoms of Depression in Low-Income Mothers

A Phase 2 study testing Modified Interpersonal Therapy in people with Depression, run by University of North Carolina, Chapel Hill at 6 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will test the effectiveness of a short-term intervention in treating depressed young mothers with young children enrolled in Early Head Start Programs. Read more about this study

Who is it for?
Ages 15 years and older, women only
Conditions the study is for
Depression
What is being tested?
Modified Interpersonal Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
226 participants
Where
6 sitesUnited States
Study dates
Jun 2003to Jan 2009
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Score of 16 or higher on the Center for Epidemiological Studies Depression (CES-D) Scale
  • Child who is 6 weeks to 30 months old
  • Child who is enrolled in an Early Head Start program

Who cannot join

  • Regular use of psychotropic medication
  • Regular use of psychotherapy or drug/alcohol treatment

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

United States6 sites
  • Asheville City Schools Preschool-Early Head Start Program

    Asheville, North Carolina, 28806

  • Chapel Hill Training Outreach Project, Inc. Early Head Start

    Chapel Hill, North Carolina, 27514

  • University of North Carolina, Chapel Hill

    Chapel Hill, North Carolina, 27599-0001

  • W.A.G.E.S., Inc. Early Head Start Program

    Goldsboro, North Carolina, 27534-2570

  • United Child Development Services, Inc. Early Head Start

    Greensboro, North Carolina, 27406

  • P.E.A.C.E, Inc. Early Head Start

    Syracuse, New York, 13203

Other trials in United States

About this study

Official title: Reducing Depressive Symptoms in Low-Income Mothers

This study will test the effectiveness of a short-term intervention in treating depressed young mothers with young children enrolled in Early Head Start Programs.

Read the detailed description

Limited resources, poor social support, and complex life problems contribute to the high prevalence and severity of depressive symptoms in low-income mothers. As depressive symptoms persist, they often rob young mothers of the energy they need for school, job training, and positive interaction with their children, which can negatively affect a child's language acquisition, intellectual development, and social conduct. This study will design and implement a home-based treatment to help young mothers manage their depressive symptoms, increase their social support, manage or resolve life issues, and effectively parent their infant or toddler through the use of EHS resources.

Mothers will be randomly assigned to receive either home-based interpersonal depression treatment or an attention control/usual care condition for 26 weeks. Assessments will be made at study start and Weeks 14, 22, and 26. Depression scales, interviews, and analyses of videotaped mother-child interactions will be used to assess participants. Stress, social support, and use of EHS services will be assessed.

Conditions
Depression
Being tested
Modified Interpersonal Therapy, Attention control/usual care
Keywords
Early Head Start Program
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Modified Interpersonal TherapyBehavioural

    Psychiatric mental health nurses will meet with participants 10 times, an hour each time, over a period of 14 weeks. The nurses will continue to work with the mothers over the next 8 weeks by phone, conducting 5 fifteen minute phone sessions.

  • Attention control/usual careBehavioural

    Participants will receive the usual care for depression.

Study groups in NCT00074789
Study groupRoleWhat they receive
1ExperimentalParticipants will receive home-based interpersonal depression treatment for 26 weeks
Receives: Behavioral: Modified Interpersonal Therapy
2Active comparatorParticipants will receive attention control/usual care for 26 weeks
Receives: Behavioral: Attention control/usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Level of depressive symptoms

    Measured: Measured at Week 26

Secondary outcomes (1)
  1. Mother child interactions

    Measured: Measured at Week 26

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2003 (estimated)
  2. Study startJun 2003
  3. Primary completionSep 2008
  4. Study completionJan 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
226 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00074789
Sponsor's protocol ID
R01MH065524
Other IDs
R01MH065524, DSIR 83-ATAS, HILDA
Status last verified
Jun 2013
First submitted
19 Dec 2003
Last updated
21 Jun 2013
Results posted
No
Data monitoring committee
Yes

Publications

  • Salomon RE, Muscatell KA, Crandell J, Anderson RA, Beeber LS. A Preliminary Investigation of Psychoneurological Symptoms in Low-Income Mothers. Nurs Res. 2021 Set/Oct 01;70(5):325-333. doi: 10.1097/NNR.0000000000000518.

    PubMed 33935214

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Modified Interpersonal Therapy in people with Depression, run by University of North Carolina, Chapel Hill at 6 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jun 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Level of depressive symptoms (time frame: Measured at Week 26). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00074789, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in